trending Market Intelligence /marketintelligence/en/news-insights/trending/-Bmw2HgTt1HkZs4n792gxQ2 content esgSubNav
In This List

Terumo's device to treat brain aneurysms gets US FDA approval

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Terumo's device to treat brain aneurysms gets US FDA approval

The U.S. Food and Drug Administration gave pre-market approval to Terumo Corp.'s FRED system to treat brain aneurysms — a bulge in a blood vessel of the brain.

The Japanese medical-device maker's product is the first blood flow director in the U.S. that uses self-expanding braided nitinol mesh to help re-direct blood flow and promote blocking or closing of an aneurysm, Terumo said in a statement.

FRED, which stands for the flow re-direction endoluminal device, was approved in the EU in 2013 and has been used in nearly 20,000 procedures.